Source: Annual Congress 2004 - Pulmonary circulation
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Halank, J. Beyer, C. Rubens, C. Marx, S. Usicenko, R. Ewert, G. Hoeffken (Dresden, Berlin, Greifswald, Germany). L-arginine plasma levels correlate with severity of primary pulmonary hypertension. Eur Respir J 2004; 24: Suppl. 48, 3460

Member's Comments

No comment yet.

Related content which might interest you: The association between pulmonary arterial hypertension secondary to chronic lung disease and serum asymmetric dimethylarginine levels Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Plasma levels of circulating cell-free DNA are increased in idiopathic pulmonary fibrosis but do not correlate with disease severity Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity Source: Eur Respir J 2005; 26: Suppl. 49, 21s Year: 2005 Fibrinogen plasma levels and disease severity in pulmonary artery hypertension Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Elevated circulating adiponectin levels in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 Serum levels of microRNA-125a are decreased in patients with precapillary pulmonary hypertension and correlate inversely with hemodynamics Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Endothelin-1 and endothelin-3 plasma levels in severe idiopathic pulmonary arterial hypertension Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology Year: 2005 Serum osteoprotegerin expression correlates with disease progression and severity in rodent models of pulmonary arterial hypertension Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Changing serum cytokines levels in patients with idiopathic pulmonary arterial hypertension treated with bosentan Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura Year: 2012 Exercise dependence of serum NT-PROBNP levels in patients with precapillary pulmonary hypertension Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Increased TNFα production in whole blood is associated with disease severity in COPD Source: Eur Respir J 2002; 20: Suppl. 38, 497s Year: 2002 Soluble LR11 level is correlated with the severity of pulmonary hypertension due to left heart disease. Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020 Elevated levels of adenosine in the lungs lead to chronic lung injury and pulmonary hypertension Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Plasma nitrite/nitrate levels: a new biomarker for pulmonary arterial hypertension? Source: Eur Respir J 2016; 48: 1265-1267 Year: 2016 Comparison of NT-proBNP and BNP in the diagnosis of pulmonary hypertension – influence of renal impairment Source: Eur Respir J 2006; 28: Suppl. 50, 425s Year: 2006 VEGF serum levels in COPD patients without pulmonary hypertension – a case control study Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Relationship between serum levels of testosterone and the severity of chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 Circulating endothelial cell levels decrease after vasodilator therapy and are a biomarker of clinical worsening in refractory pulmonary hypertension in children Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Sitaxsentan for pulmonary arterial hypertension (PAH) patients with clinical deterioration or significantly abnormal liver function test on bosentan Source: Eur Respir J 2005; 26: Suppl. 49, 563s Year: 2005 Relationship between severity of disease and D-dimer levels which were measured with two different methods in pulmonary embolism patients Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases Year: 2009